You are here: Home > Investor Relations

 Investor Relations

 
 Recent Releases

 Archived Releases

 Annual Meeting

 Analyst Coverage

 Corporate Governance

 SEC Filings

 XBRL Interactive Data
 Files


 Transfer Agent

 Auditors

 E-Mail Alerts
 
 Contact Us

7/15/2014 Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for ELI-201

6/30/2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014
Revenues Increase by 35%, Product Development Accelerating
Conference Call Scheduled for Tuesday, July 1 at 12:00 PM EDT


6/26/2014 Elite Pharmaceuticals, Inc. to Host 2014 Fiscal Year End Conference Call on Tuesday, July 1, 2014
.Fiscal Year Ended March 31, 2014 Financials Are Scheduled To Be Filed on Monday, June 30, 2014


6/10/2014 Elite Pharmaceuticals Enters Into $5 Million Settlement Agreement with Novel Laboratories

6/9/2014 Elite Pharmaceuticals Begins Human Abuse Liability Studies for ELI-200

More Releases...

Click Here for a complete archive


Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com